Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Share-based Compensation (2021 - 2025)

Zymeworks' Share-based Compensation history spans 5 years, with the latest figure at $8.8 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 76.26% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.0 million, a 57.57% increase, with the full-year FY2025 number at $28.0 million, up 57.57% from a year prior.
  • Share-based Compensation hit $8.8 million in Q4 2025 for Zymeworks, up from $6.9 million in the prior quarter.
  • Over the last five years, Share-based Compensation for ZYME hit a ceiling of $8.8 million in Q4 2025 and a floor of -$8.2 million in Q1 2022.
  • Historically, Share-based Compensation has averaged $3.3 million across 5 years, with a median of $4.5 million in 2022.
  • Biggest five-year swings in Share-based Compensation: plummeted 87.32% in 2023 and later surged 1141.14% in 2024.
  • Tracing ZYME's Share-based Compensation over 5 years: stood at -$1.7 million in 2021, then skyrocketed by 366.15% to $4.5 million in 2022, then fell by 25.08% to $3.4 million in 2023, then skyrocketed by 48.99% to $5.0 million in 2024, then skyrocketed by 76.26% to $8.8 million in 2025.
  • Business Quant data shows Share-based Compensation for ZYME at $8.8 million in Q4 2025, $6.9 million in Q3 2025, and $5.9 million in Q2 2025.